Aligos Therapeutics annual capital expenditures (capex)
2019
2020
2021
2022
2023
2024
2025
Aligos Therapeutics Capital Expenditures (CapEx) Growth & History (ALGS)
Aligos Therapeutics's capital expenditures (capex) was $437,000 for fiscal 2025.
View full Aligos Therapeutics company overviewAligos Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $437,000 | $307,000 | +236.15% |
| 2024 | 2024-12-31 | $130,000 | $111,000 | +584.21% |
| 2023 | 2023-12-31 | $19,000 | −$924,000 | −97.99% |
| 2022 | 2022-12-31 | $943,000 | $51,000 | +5.72% |
| 2021 | 2021-12-31 | $892,000 | −$1.2M | −56.78% |
| 2020 | 2020-12-31 | $2.1M | −$722,000 | −25.92% |
| 2019 | 2019-12-31 | $2.8M | — | — |
Aligos Therapeutics quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1,000 | −$108,000 | −99.08% |
| Q1 2026 | 2026-03-31 | $69,000 | — | — |
| Q4 2025 | 2025-12-31 | $92,000 | — | — |
| Q3 2025 | 2025-09-30 | $193,000 | — | — |
| Q2 2025 | 2025-06-30 | $109,000 | — | — |
| Q1 2023 | 2023-03-31 | $7,000 | −$508,000 | −98.64% |
| Q4 2022 | 2022-12-31 | $91,000 | −$245,000 | −72.92% |
| Q3 2022 | 2022-09-30 | $3,000 | −$94,000 | −96.91% |
| Q2 2022 | 2022-06-30 | $334,000 | $182,000 | +119.74% |
| Q1 2022 | 2022-03-31 | $515,000 | $208,000 | +67.75% |
| Q4 2021 | 2021-12-31 | $336,000 | $275,000 | +450.82% |
| Q3 2021 | 2021-09-30 | $97,000 | −$247,000 | −71.80% |
| Q2 2021 | 2021-06-30 | $152,000 | −$417,000 | −73.29% |
| Q1 2021 | 2021-03-31 | $307,000 | −$783,000 | −71.83% |
| Q4 2020 | 2020-12-31 | $61,000 | — | — |
| Q3 2020 | 2020-09-30 | $344,000 | — | — |
| Q2 2020 | 2020-06-30 | $569,000 | — | — |
| Q1 2020 | 2020-03-31 | $1.1M | — | — |
Aligos Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Aligos Therapeutics's capital expenditures (capex) decreased from $2.1M to $437,000, a change of −$1.6M. The latest reported quarter, Q2 2026, shows $1,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aligos Therapeutics source filings ↗